Industries > Pharma > Global OTC Pharmaceutical Market Forecast 2018-2028

Global OTC Pharmaceutical Market Forecast 2018-2028

Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies

PUBLISHED: 05 April 2018
PAGES: 201
PRODUCT CODE: PHA0298

Clear
WOOCS 2.2.1

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 84 tables and 79 figures– all unavailable elsewhere.

The 201-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global OTC Pharmaceutical Market forecasts from 2018-2028

• This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
• Analgesics
• Cough, cold and allergy products
• Dermatological products
• Gastrointestinal products
• Eye Care
• Smoking Cessation Aids
• Other products

Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: the US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of the World: Middle East, Africa, Other Countries

Global OTC Pharmaceutical Market Forecast 2018-2028

Our study provides a SWOT analysis and Porter’s Five Forces analysis of the Global OTC Pharmaceutical market

This report discusses the leading companies in the Global OTC Pharmaceutical market
• Bayer AG
• GlaxoSmithKline (GSK) Consumer Care
• Perrigo Company PLC
• Johnson & Johnson
• Daiichi Sankyo Co., Ltd
• Pfizer Inc.
• Procter & Gamble
• Sanofi S.A
• Reckitt Benckiser Group PLC
• Cipla, Inc.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Buy our report today Global OTC Pharmaceutical Market Forecast 2018-2028: Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2018-2028


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories